Davis Polk advised the representatives of the several underwriters in connection with a $37.5 million public offering of 25,000,000 shares of common stock of Surgalign Holdings, Inc. at $1.50 per share. Surgalign’s common stock is listed on the Nasdaq Global Select Market under the symbol “SRGA.”
Surgalign is a global medical technology company focused on advancing the science of spine care by delivering innovative solutions, including the application of digital technologies, to drive superior patient outcomes. Surgalign Holdings is headquartered in Deerfield, Illinois.
The Davis Polk corporate team included partner Alan F. Denenberg and associates Tierney O’Rourke, Jonathan Bye and Lawrence Edward Traylor Jr. Partner Mario J. Verdolini and associate Bradford Sherman provided tax advice. Partner David R. Bauer and associate Jay Frankel provided intellectual property advice. Counsel Marcie A. Goldstein provided FINRA advice. Members of the Davis Polk team are based in the Northern California and New York offices.